INX Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Diversified Specialty-distribution ModelIMCD's distribution model combines logistics, technical application know-how, and formulation support across pharma, food, personal care, coatings and industrial end markets. This diversified, value‑added model drives sticky customer relationships, cross‑selling and structural resilience over months.
Strong Free Cash Flow ConversionConsistent FCF conversion near parity with net income indicates high earnings quality and reliable cash generation. Durable free cash flow supports dividends, selective M&A, working capital needs and de‑leveraging, preserving optionality through industry cycles over the medium term.
Historical Revenue Growth And Resilient ProfitabilityPrior multi‑year top‑line growth demonstrates successful commercial expansion and principal relationships. The business maintaining healthy operating profitability even after 2025 margin pressure suggests structural cost/scale advantages and resilience in core operations over the next several months.
Bears Say
2025 Margin DeteriorationMaterial margin compression in 2025 weakens sustainable profitability and return metrics. If driven by structural mix shifts, pricing pressure, or rising input costs, the deterioration can persist and reduce reinvestment capacity, dividend coverage and ROE for multiple quarters.
Rising LeverageLeverage rising into the high 0.7–0.8x range constrains balance‑sheet flexibility for a distributor that needs working capital and acquisitive optionality. Higher debt increases interest exposure and limits room for strategic investments if margins remain pressured over the medium term.
EPS ContractionA near‑15% EPS decline signals deterioration in earnings power versus prior periods. Sustained negative EPS growth can erode ROE, limit cash available for dividends or buybacks, and hamper the company's ability to fund growth or absorb cyclicality in coming quarters.
IMCD N.V. News
INX FAQ
What was IMCD N.V.’s price range in the past 12 months?
Currently, no data Available
What is IMCD N.V.’s market cap?
IMCD N.V.’s market cap is CHF5.11B.
When is IMCD N.V.’s upcoming earnings report date?
IMCD N.V.’s upcoming earnings report date is Nov 05, 2026 which is in 96 days.
How were IMCD N.V.’s earnings last quarter?
IMCD N.V. released its earnings results on Jul 29, 2026. The company reported CHF2.953 earnings per share for the quarter, missing the consensus estimate of CHF3.185 by -CHF0.232.
Is IMCD N.V. overvalued?
According to Wall Street analysts IMCD N.V.’s price is currently Undervalued.
Does IMCD N.V. pay dividends?
IMCD N.V. does not currently pay dividends.
What is IMCD N.V.’s EPS estimate?
IMCD N.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IMCD N.V. have?
IMCD N.V. has 59,107,998 shares outstanding.
What happened to IMCD N.V.’s price movement after its last earnings report?
IMCD N.V. reported an EPS of CHF2.953 in its last earnings report, missing expectations of CHF3.185. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of IMCD N.V.?
Currently, no hedge funds are holding shares in CH:INX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IMCD N.V.
Founded in Rotterdam, the Netherlands, in 1995, IMCD N.V. operates as a leading global distributor and marketer of a diverse range of specialized chemicals and premium ingredients. Its extensive operations span across the Netherlands, the wider European continent, the Middle East, Africa, both North and South America, and the Asia-Pacific region. IMCD's comprehensive product portfolio serves numerous industries. For the pharmaceutical, agrochemical, and nutraceutical sectors, it provides essential active ingredients, excipients, formulation components, and compounds for regulated synthesis. Within personal care and cosmetics, the company supplies a wide array of offerings including active substances, UV filters, rheology modifiers, thickeners, emulsifiers, emollients, colorants, fragrances, and various functional additives for skin and hair products. Industrial applications benefit from resins, binders, functional fillers, and specialized solvents. Additionally, IMCD offers solutions for the food and beverage industry, focusing on enhancing taste, improving texture, and boosting nutritional value. The company also supports the energy sector with base oils, fuel and lubricant additives, and related fluids, alongside a broad spectrum of bio-based chemicals, catalysts, intermediates, and organic building blocks for various chemical processes.
INX Stock 12 Month Forecast
Average Price Target
CHF101.75